Mycophenolate mofetil therapy for children with intractable nephrotic syndrome

Pediatrics International

Volumn 49, Issue 6, 2007, Pages 933-937

  Okada, Mitsuru ^a   Sugimoto, Keisuke ^a   Yagi, Kazuro ^a   Yanagida, Hidehiko ^a   Tabata, Nobutada ^a   Takemura, Tsukasa ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclosporine; Focal segmental glomerulosclerosis; Frequent relapse nephrotic syndrome; Minimal change disease; Mycophenolate mofetil; Steroid resistant nephrotic syndrome

Indexed keywords

ANTIULCER AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HISTAMINE H2 RECEPTOR ANTAGONIST; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALOPECIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SCREENING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MORBIDITY; NAUSEA; NEPHROTIC SYNDROME; PEDIATRICS; PRIORITY JOURNAL; RELAPSE; REMISSION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; CHILD; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; NEPHROTIC SYNDROME; PREDNISOLONE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 36649030396     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02487.x     Document Type: Article

References (18)

1. Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am. J. Kidney Dis. 1998 32 : 72 9.
2. Hino S, Takemura T, Okada M et al. Follow-up of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine. Am. J. Kidney Dis. 1998 31 : 932 9.
3. Okada M, Hino S, Takemura T, Fukushima K, Yoshioka K. Cyclosporine therapy in children with steroid-resistant nephrotic syndrome. Clin. Exp. Nephrol. 1999 3 : S34 9.
4. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft rejections: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 1997 63 : 39 47.
5. Allison AC, Eugui M. Immunosuppressive and other effects of mycophenolate acid ester prodrug, mycophenolate mofetil. Immunol. Rev. 1993 136 : 5 28.
6. Contreras G, Pardo V, Leclercq B et al. Sequential therapies for proliferative lupus nephritis. N. Engl. J. Med. 2004 350 : 971 80.
7. Miller G, Zimmerman R III., Radharkrishnan J, Appel G. Use mycophenolate mofetil in resistant membranous nephropathy. Am. J. Kidney Dis. 2000 36 : 250 56.
8. Day CJ, Cockwell P, Lipken GW, Savage CO, Howie AJ, Adu D. Mycophenolate mofetil in treatment of resistant idiopathic nephrotic syndrome. Nephrol. Dial. Transplant. 2002 17 : 2011 13.
9. Bagga A, Hara P, Moudgil A, Jordan SC. Mycophenolate mofetil and predonisolone therapy in children with steroid-dependent nephrotic syndrome. Am. J. Kidney Dis. 2003 42 : 1114 20.
10. Waldo FB, Benfield MR, Kohaut EC. Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Pediatr. Nephrol. 1998 12 : 397 400.
11. Iijima K, Hamahira K, Tanaka R et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int. 2002 59 : 1801 5.
12. Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segment glomerulosclerosis. J. Am. Soc. Nephrol. 1995 5 : 1820 25.
13. Choi MJ, Eustace JA, Gimenez LF et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int. 2002 61 : 1098 114.
14. Bayazit AK, Noyan A, Cengiz N, Anarat A. Mycophenolate mofetil in children with multidrug-resistant nephrotic syndrome. Clin. Nephrol. 2004 61 : 25 9.
15. Gellermann J, Querfeld U. Frequently relapsing nephrotic syndrome: Treatment with mycophenolate mofetil. Pediatr. Nephrol. 2004 19 : 101 4.
16. Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr. Nephrol. 2003 18 : 833 7.
17. Von Gelder T, Shaw LM. The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation. Transplantation 2005 80 : S244 53.
18. Chandra M, Susin M, Abitbol C. Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil. Pediatr. Nephrol. 2000 14 : 224 6.